Target intelligence / Profile preview

Rotavirus structural proteins VP4 and VP7 (VP4/VP7)

Target
VP4/VP7
Molecular classification
Viral structural protein, Spike protein, Glycoprotein, Antigen
01

Overview

Rotavirus structural proteins VP4 and VP7 are the primary components of the virus's outer capsid and serve as the critical determinants of viral infectivity and host range. VP4 is a non-glycosylated, protease-sensitive spike protein that mediates attachment to host cell receptors, such as sialic acids or integrins, and undergoes trypsin cleavage to facilitate membrane penetration [1.2.2, 1.3.1]. VP7 is a calcium-dependent glycoprotein that forms the outer shell of the virion and is essential for stabilizing the capsid and mediating cell entry [1.3.3, 1.4.1]. Together, these proteins define the G (VP7) and P (VP4) serotypes, which are the basis for rotavirus classification and the primary targets for neutralizing antibodies [1.2.1, 1.2.5]. Therapeutic strategies primarily involve live-attenuated vaccines like Rotarix and RotaTeq, which induce protective immunity against these antigens to prevent severe gastroenteritis in infants [1.1.1, 1.1.2]. Emerging research also investigates monoclonal antibodies and small-molecule inhibitors designed to block the attachment and uncoating processes mediated by these proteins [1.3.1, 1.3.3].

Other names
Outer capsid proteinsVP4 spike proteinVP7 glycoproteinP proteinG proteinProtease-sensitive proteinGlycoprotein
02

Mechanism of action

Induction of neutralizing antibodies that bind to VP4 and VP7, preventing viral attachment to host receptors and inhibiting the uncoating process required for cell entry [1.1.1, 1.3.3].

03

Biological functions

Viral attachmentCell entryMembrane penetrationCapsid assemblyHost cell recognition
04

Disease associations

InfectionGastroenteritisDehydration
05

Safety considerations

IntussusceptionVaccine-derived reassortmentShedding of vaccine virusGenotype escape
06

Interacting drugs

Rotarix

3 more in the full profile.

07

Biomarkers

VP7-specific antibodiesVP4-specific antibodiesRotavirus-specific IgAStool rotavirus antigenG/P genotype

Beyond the preview

Go deeper on Rotavirus structural proteins VP4 and VP7 (VP4/VP7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rotavirus structural proteins VP4 and VP7 (VP4/VP7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call